Astrazeneca Share News (AZN)

Astrazeneca Information

Buy AZN Shares
Add AZN to Watchlist
Add AZN to Alert

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 12,416.00

Bid: 12,408.00

Ask: 12,410.00

Change: -12.00 (-0.10%)

Spread: 2.00 (0.016%)

Open: 12,474.00

High: 12,480.00

Low: 12,350.00

Prev. Close: 12,428.00

Last checked at -

UK earnings, trading statements calendar - next 7 days

Thu, 18th Apr 2024 14:17

Friday 19 April
888 Holdings PLC	Trading Statement
Man Group PLC	Trading Statement
Monday 22 April
Brave Bison Group PLC	Full Year Results
Elixirr International PLC	Full Year Results
Frenkel Topping Group PLC	Full Year Results
Mobico Group PLC	Full Year Results
South32 Ltd	Q3 Results
Ten Lifestyle Group PLC	Half Year Results
Tuesday 23 April
Alliance Pharma PLC	Full Year Results
Alphawave IP Group PLC	Full Year Results
Anglo American PLC	Trading Statement
ASA International Group PLC	Full Year Results
Associated British Foods PLC	Half Year Results
Eleco PLC	Full Year Results
GB Group PLC	Trading Statement
Jupiter Fund Management PLC	Trading Statement
Maintel Holdings PLC	Full Year Results
Property Franchise Group PLC	Full Year Results
Taylor Wimpey PLC	Trading Statement
tinyBuild Inc	Full Year Results
Trellus Health PLC	Full Year Results
Wednesday 24 April
1Spatial PLC	Full Year Results
abrdn PLC	Trading Statement
Ecora Resources PLC	Trading Statement
Fresnillo PLC	Trading Statement
Lloyds Banking Group PLC	Q1 Results
Nichols PLC	Trading Statement
PensionBee Group PLC	First Quarter Results
PZ Cussons PLC	Trading Statement
Reckitt Benckiser Group PLC	Trading Statement
Sanderson Design Group PLC	Full Year Results
Serica Energy PLC	Full Year Results
Star Energy Group PLC	Full Year Results
Tortilla Mexican Grill PLC	Full Year Results
Tracsis PLC	Half Year Results
Warpaint London PLC	Full Year Results
Thursday 25 April
Aquila European Renewables PLC	Full Year Results
Argo Blockchain PLC	Full Year Results
AstraZeneca PLC	Q1 Results
Barclays PLC	Q1 Results
Checkit PLC	Full Year Results
Coca-Cola Europacific Partners PLC	Trading Statement
Destiny Pharma PLC	Full Year Results
Hikma Pharmaceuticals PLC	Trading Statement
Focusrite PLC	Half Year Results
Ibstock PLC	Trading Statement
Inchcape PLC	Trading Statement
J Sainsbury PLC	Full Year Results
London Stock Exchange Group PLC	Q1 Results
Persimmon PLC	Trading Statement
PPHE Hotel Group Ltd	Trading Statement
PureTech Health PLC	Full Year Results
Relx PLC	Trading Statement
Renewi PLC	Trading Statement
Schroders PLC	Q1 Results
Skillcast Group PLC	Full Year Results
Travis Perkins PLC	Trading Statement
Trifast PLC	Trading Statement
Unilever PLC	Q1 Results
WAG Payment Solutions PLC	Trading Statement
Weir Group PLC	Trading Statement
WH Smith PLC	Half Year Results
WPP PLC	Trading Statement
Zinc Media Group PLC	Full Year Results

Comments and questions to newsroom@alliancenews.com

A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News

18 Jun 2024 09:33

TOP NEWS: AstraZeneca disappointed by breast cancer drug trial results

(Alliance News) - AstraZeneca PLC on Tuesday said findings from a breast cancer drug trial showed that Truqap did not meet its primary endpoints.

18 Jun 2024 07:51

LONDON BRIEFING: Ashtead profit declines; Whitbread sales rise

(Alliance News) - London's FTSE 100 is called to open higher on Tuesday, taking confidence from a decent showing for US equities overnight, with inflation data and central bank decisions the key plot points as the week progresses.

18 Jun 2024 07:17

AstraZeneca trial fails to treat 'challenging' breast cancer

(Sharecast News) - AstraZeneca announced on Tuesday that the phase three 'CAPItello-290' trial for 'Truqap', or capivasertib, in combination with paclitaxel did not achieve its primary endpoints.

17 Jun 2024 09:09

TOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in US

(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "important new option" for patients.

17 Jun 2024 07:48

LONDON BRIEFING: Astra gets US drug approval; Ascential trades in line

(Alliance News) - London's FTSE 100 is called to open solidly higher on Monday, recovering some poise after a tricky week, with eyes turning to the Bank of England.

17 Jun 2024 07:23

IN BRIEF: AstraZeneca gets positive cancer test results for Calquence

AstraZeneca PLC - Cambridge, England-based pharmaceutical maker - Reports promising test results for one of its cancer therapies. The Echo phase III trial shows that Calquence, when used in combination with bendamustine and rituximab, demonstrates a clinically meaningful improvement in progression-free survival in patients with untreated mantle cell lymphoma. Compared to standard-of-care chemoimmunotherapy, the combination with Calquence, whose generic name is acalabrutinib, shows a 27% reduced risk of disease progression or death. Mantle cell lymphoma is rare and typically aggressive form of non-Hodgkin lymphoma, Astra explains.

17 Jun 2024 07:15

AstraZeneca's Imfinzi gets US approval for endometrial cancer patients

(Sharecast News) - AstraZeneca said its Imfinzi cancer treatment had been approved in the US as treatment for adult patients with primary advanced or recurrent endometrial cancer.

12 Jun 2024 20:56

AstraZeneca's Farxiga approved to treat paediatric type-2 diabetes

(Alliance News) - AstraZeneca PLC on Wednesday said its Farxiga treatment has been approved in the US to treat some diabetes sufferers.

10 Jun 2024 09:10

LONDON BROKER RATINGS: JPMorgan cuts Aviva but lifts M&G

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

10 Jun 2024 08:30

TOP NEWS: Astra's Tagrisso gets US priority review for lung cancer

(Alliance News) - AstraZeneca PLC on Monday celebrated a breakthrough therapy designation for its cancer drug Tagrisso, aimed at treating a form of non-small cell lung cancer.

10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

10 Jun 2024 06:25

London pre-open: Stocks set for lower start after EU elections

(Sharecast News) - Stocks in London look primed for a lower start as investors digest the gains made by far right parties in Austria, Germany, but above all France, at the European Union elections that were held at the weekend.

5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

5 Jun 2024 09:27

AstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchase

(Alliance News) - AstraZeneca PLC on Wednesday said it successfully completed the acquisition of Boston, Massachusetts-based Fusion Pharmaceuticals Inc.

3 Jun 2024 08:59

AstraZeneca cancer treatment Tagrisso recommended for approval in EU

(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the European Union.

Latest Share Chat

Astrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Login to your account

Quickpicks are a member only feature

Login to your account